Holen Sie sich die Stockscreener-App
37.11
2.51%
0.91
Handel nachbörslich:
36.93
-0.18
-0.49%
Atricure Inc Aktie (ATRC) Neueste Nachrichten
First Week of March 20th Options Trading For AtriCure (ATRC) - Nasdaq
AtriCure (NASDAQ:ATRC) Stock Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Wave Life Sciences (WVE) and Arcellx Inc (ACLX) - The Globe and Mail
AtriCure, Inc. (ATRC) Stock Analysis: A Compelling 43% Upside Potential For Investors - DirectorsTalk Interviews
AtriCure stock maintains Overweight rating at Piper Sandler on BoxX-NoAF potential - Investing.com India
(ATRC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Local public company secures incentive for $45M project, likely to create hundreds of jobs - WKRC
Income Plays: Is AtriCure Inc a cyclical or defensive stock2025 Technical Patterns & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Weekly Recap: Will ARS Pharmaceuticals Inc announce a stock splitJuly 2025 Outlook & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Red-hot medical device firm gets big JobsOhio grant for $45M expansion - The Business Journals
Reasons to Retain Avanos Medical Stock in Your Portfolio Now - sharewise.com
Market Wrap: Does AtriCure Inc have declining or rising EPSJuly 2025 Technicals & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Riverwater Partners LLC Buys 26,657 Shares of AtriCure, Inc. $ATRC - MarketBeat
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results - Business Wire
The Zacks Analyst Blog Highlights AtriCure, REV Group, Oceaneering International and Analog Devices - Yahoo Finance
Market Pulse: Is AtriCure Inc stock trending bullish2025 Investor Takeaways & Real-Time Volume Spike Alerts - baoquankhu1.vn
SG Americas Securities LLC Has $824,000 Position in AtriCure, Inc. $ATRC - MarketBeat
(ATRC) Risk Channels and Responsive Allocation - Stock Traders Daily
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
AtriCure (ATRC) Is Down 5.8% After Issuing 2026 Profitability Guidance And Expanding Credit Facility - Yahoo Finance
What are AtriCure Incs recent SEC filings showingMarket Growth Review & Long-Term Safe Return Strategies - baoquankhu1.vn
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results - Prime Publishers, Inc.
AI Diagnostics: The End of the High-Cost Imaging Era - GlobeNewswire
AtriCure Stock (+11%): Profitability Inflection Ignites Re-Rate - Trefis
AtriCure (NASDAQ:ATRC) Trading 6.7% HigherHere's Why - MarketBeat
AtriCure Inc (ATRC) Shares Up 8.49% on Jan 15 - GuruFocus
AtriCure CEO Touts $10B AFib and Pain Market, Raises EBITDA Outlook at JPMorgan Conference - MarketBeat
Momentum Shift: Is AtriCure Inc a potential multi baggerRate Cut & Reliable Price Action Trade Plans - baoquankhu1.vn
ATRC: Innovation and clinical evidence drive growth in AFib and pain management, with strong financial results - TradingView
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Boston Scientific (BSX) - The Globe and Mail
Street Watch: What is AtriCure Incs revenue forecastBear Alert & Low Risk Investment Opportunities - baoquankhu1.vn
AtriCure reports 13% revenue growth in Q4 2025, provides 2026 outlook - Investing.com Nigeria
AtriCure (NASDAQ:ATRC) Shares Down 7.6%Time to Sell? - MarketBeat
AtriCure, Inc. and AtriCure, LLC Enter into a First Amendment to Credit Agreement - marketscreener.com
ATRC: Projected Strong Revenue and Growth by 2026 - GuruFocus
AtriCure reports 13% revenue growth in Q4 2025, provides 2026 outlook By Investing.com - Investing.com South Africa
AtriCure (NASDAQ:ATRC) Releases Q4 2025 Earnings Guidance - MarketBeat
AtriCure (ATRC) Anticipates Strong Revenue Growth in Q4 2025 - GuruFocus
AtriCure's preliminary Q4 revenue rises 13%, slightly beats estimates - TradingView
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026 - FinancialContent
AtriCure Reports Strong Preliminary 2025 Revenue Growth - TipRanks
AtriCure IncEnters first amendment to credit agreementSEC filing - marketscreener.com
AtriCure Signs First Amendment to Credit Agreement With JPMorgan Chase Bank - TradingView — Track All Markets
A Look At AtriCure (ATRC) Valuation As Earnings Beats And Analyst Optimism Lift Confidence - simplywall.st
Jobs Data: Why is AtriCure Inc stock going down2025 Fundamental Recap & Stock Portfolio Risk Management - baoquankhu1.vn
AtriCure, Inc. (ATRC) soars to 52-week high, time to cash out? - MSN
Will AtriCure Inc. stock benefit from green energy trendsJuly 2025 Intraday Action & Risk Controlled Daily Trade Plans - Улправда
(ATRC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
AtriCure, Inc. (ATRC) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Is AtriCure Inc. stock a defensive play in 2025July 2025 Movers & Fast Gaining Stock Strategy Reports - Улправда
Will AtriCure Inc. stock benefit from automationJuly 2025 Short Interest & High Return Trade Guides - Улправда
Will AtriCure Inc. stock continue upward momentumQuarterly Risk Review & AI Powered Trade Plan Recommendations - Улправда
Will AtriCure Inc. stock attract ESG investorsJuly 2025 Breakouts & High Accuracy Trade Alerts - Улправда
AtriCure (NASDAQ:ATRC) Reaches New 12-Month HighWhat's Next? - MarketBeat
6.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):